Diaceutics announces 30 jobs on back of 60% revenue growth

Diaceutics, the Irish data insights and solutions company enabling better patient testing globally, has announced 30 new jobs as it continues to lead the... Read More
April 24, 2017

Top three global diagnostics company takes exclusive rights to several of Avacta’s Affimer reagents

Avacta Group plc (AIM: AVCT) (Avacta), the developer of Affimer® biotherapeutics and research reagents, is pleased to report that an evaluation of the Affimer... Read More
April 21, 2017

Verily Launches Landmark Study With Duke and Stanford as First Initiative of Project Baseline

Verily Life Sciences LLC, an Alphabet company, in partnership with Duke University School of Medicine and Stanford Medicine, announced the initiation of the Project... Read More
April 21, 2017

Congenica and Edico Genome Partner to Speed Analysis from ‘DNA to Diagnosis’ for Inherited Diseases

CAMBRIDGE, UK and SAN DIEGO – April 20, 2017 – Congenica and Edico Genome announced the companies have partnered to offer their complementary platform... Read More
April 21, 2017

JAX’S Maine Cancer Genomics Initiative Achieves Key Milestones In Bringing Precision Cancer Care To Maine

The Jackson Laboratory (JAX), an independent, nonprofit biomedical research institution, announced that its Maine Cancer Genomics Initiative (MCGI) has accomplished key milestones toward its... Read More
March 2, 2017

Dr. Stephen Kingsmore – A Vision for Transforming Medicine with Rapid Genome Sequencing (Part 1)

Dr. Stephen Kingsmore, MD, DSc, is the President and CEO of the Rady Pediatric Genomics and Systems Medicine Institute. Dr. Kingsmore spoke at the... Read More
March 1, 2017

Freenome Announces $65 Million in Series A Funding, Led by Andreessen Horowitz

Freenome, the health technology company reinventing disease management through systematized early detection and intervention, announced today that it has raised $65 million USD in... Read More
March 1, 2017

Illumina Announces the iHope Network, an Expansion of Its iHope Philanthropic Clinical Whole Genome Sequencing Program

Illumina, Inc. has announced the launch of the iHope Network, a consortium of member institutions who have committed to providing clinical whole genome sequencing... Read More
March 1, 2017

Bristol-Myers Squibb Expands Focus on Precision Medicine with Investment and Planned Collaboration with GRAIL on Blood-Based Cancer Screening

Bristol-Myers Squibb Company announced today its equity investment and plans for a research collaboration with GRAIL Inc., a life sciences company whose mission is... Read More
February 23, 2017

Orion Health Begins Migration of Patient Records to Amazon Web Services

Orion Health™ has announced the company will migrate its Amadeus precision medicine platform to the Amazon Web Services, Inc. (AWS) Cloud. Orion Health’s software... Read More
February 23, 2017

Cancer Experience Survey Reveals Gap in Educating Patients on Latest Diagnostic and Treatment Advancements

More than two-thirds of cancer patients and their caregivers have limited knowledge about the latest advancements in diagnostic and treatment options to help inform... Read More
February 23, 2017

Cancer Patients Can Now Read a Molecular Analysis of Their Cancer That They Can Understand

Perthera, Inc., a full-service precision medicine company, has developed a report empowering cancer patients to make informed decisions regarding their treatment options. Perthera began... Read More
February 23, 2017

SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards

SeraCare Life Sciences, Inc. announced the launch of Seraseq™ Fusion RNA Mix v2 and Seraseq FFPE Fusion RNA Reference Material v2. The two new... Read More
February 9, 2017

Epinomics to Collaborate with the Parker Institute for Cancer Immunotherapy at Stanford University to Bring Precision Medicine to Cancer Immunotherapies

Researchers from Epinomics will collaborate with the research team led by Crystal Mackall, MD, director of the Parker Institute for Cancer Immunotherapy at Stanford,... Read More
February 7, 2017

Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation of Microbiome Science into Health Solutions

Janssen Research & Development, LLC (Janssen)  has announced several new collaborations through its Janssen Human Microbiome Institute (JHMI) focused on advancing the discovery, development... Read More
February 7, 2017

MD Anderson and Guardant Health Announce Partnership to Make Comprehensive Liquid Biopsy Part of Oncology Standard of Care

The University of Texas MD Anderson Cancer Center and Guardant Health have announced a multi-year partnership designed to accelerate comprehensive liquid biopsy technology into... Read More